IN8bio, Inc. (INAB) Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IN8bio, Inc. on May 7, 2026. The filing primarily reports the results of the Company's 2026 Annual Meeting of Stockholders held on the same date and references the issuance of a press release regarding financial results for the first quarter ended March 31, 2026.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing financial results for the quarter ended March 31, 2026. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the referenced press release for these details.
Material Changes and Corporate Actions
The most significant material change reported is the stockholder approval of the Amended and Restated 2026 Equity Incentive Plan (the "2026 Plan"). Key modifications to the plan include:
- An increase of 2,920,000 shares available for issuance.
- Extension of the annual share increase provision through 2037.
- Establishment of a 20,000,000 share maximum for Incentive Stock Options (ISOs).
- Extension of the ISO grant outside date to the tenth anniversary of the plan's adoption.
- Revision to the annual increase formula to include shares issuable upon settlement of outstanding pre-funded warrants.
Outlook, Risks, and Management Commentary
The filing does not contain specific management commentary on future outlook, risks, or contingencies beyond the standard incorporation of the press release by reference. The approval of the 2026 Plan indicates management's intent to continue utilizing equity incentives for employee retention and motivation.
Annual Meeting Results
Stockholders voted on three proposals at the Annual Meeting:
- Election of Directors: Peter Brandt and Corinne Epperly were elected as Class II directors. Corinne Epperly received significantly higher support (approx. 99.3% for) compared to Peter Brandt (approx. 74.6% for), with a notable number of votes withheld for Brandt.
- Ratification of Auditors: The selection of CohnReznick LLP as the independent registered public accounting firm was ratified with overwhelming support (approx. 99.0% for).
- Equity Incentive Plan: The 2026 Plan was approved, though it faced more opposition than the other proposals, with approximately 68.8% voting for and 31.2% voting against or abstaining.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 financial metrics (revenue, net loss, cash position) which are not detailed in this filing.
- Analyze the high number of votes withheld for director Peter Brandt to understand potential shareholder concerns.
- Examine the full text of the Amended and Restated 2026 Equity Incentive Plan (Exhibit 10.1) to assess dilution risks from the increased share pool and pre-funded warrant provisions.
- Verify the impact of the 2026 Plan changes on the company's future capital structure and employee compensation costs.